SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
American Journal of Alzheimer's Disease and Other Dementias®
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Dintchov Traykov, L.
Right arrow Articles by Van Broeckhoven, C.
PubMed
Right arrow Articles by Dintchov Traykov, L.
Right arrow Articles by Van Broeckhoven, C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Novel PSEN1 Mutation in a Bulgarian Patient With Very Early-Onset Alzheimer’s Disease, Spastic Paraparesis, and Extrapyramidal Signs

Latchezar Dintchov Traykov, MD, PhD, DSc

Department of Neurology, Medical University, Sofia, Bulgaria, traykov_l{at}yahoo.fr

Shima Mehrabian, MD, PhD

Department of Neurology, Medical University, Sofia, Bulgaria

Marleen Van den Broeck, MSc

Department of Molecular Medicine Center, Medical University, Sofia, Bulgaria, Neurodegenerative Brain Diseases Group, Department of Molecular Genetics, VIB, Antwerpen, Belgium, Department of Neurology, Medical University, Sofia, Bulgaria

Margarita Radoslavova Raycheva, PhD

Laboratory of Neurogenetics, Institute Born-Bunge and University of Antwerp, Antwerpen, Belgium, Neurodegenerative Brain Diseases Group, Department of Molecular Genetics, VIB, Antwerpen, Belgium

Marc Cruts, PhD

Laboratory of Neurogenetics, Institute Born-Bunge and University of Antwerp, Antwerpen, Belgium, Neurodegenerative Brain Diseases Group, Department of Molecular Genetics, VIB, Antwerpen, Belgium

Albena Kirilova Jordanova, PhD

Department of Chemistry and Biochemistry, Medical University, Sofia, Bulgaria, Laboratory of Neurogenetics, Institute Born-Bunge and University of Antwerp, Antwerpen, Belgium

Christine Van Broeckhoven, PhD, DSc

Laboratory of Neurogenetics, Institute Born-Bunge and University of Antwerp, Antwerpen, Belgium, Neurodegenerative Brain Diseases Group, Department of Molecular Genetics, VIB, Antwerpen, Belgium

We describe the phenotype of a Bulgarian early-onset Alzheimer’s disease (EOAD) family with 3 affected patients in 3 generations. In the proband, a novel L381V mutation in the presenilin1 (PSEN1) gene was identified. In this patient, the first symptoms were noticed at the age of 32 years and she died at the age of 37 years. The EOAD phenotype caused by the novel L381V mutation in the PSEN1 gene presented clinically, by a very early onset in the proband, rapid progression of dementia, spastic paraparesis, and extrapyramidal signs, as atypical clinical signs in Alzheimer’s disease patients.

Key Words: early onset Alzheimer’s disease • presenilin 1 • spastic paraparesis • parkinsonism

American Journal of Alzheimer's Disease and Other Dementias®, Vol. 24, No. 5, 404-407 (2009)
DOI: 10.1177/1533317509341464


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement